Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$0.42 - $0.72 $182 - $313
-435 Reduced 6.92%
5,853 $3,000
Q3 2023

Oct 25, 2023

SELL
$0.6 - $1.53 $293 - $748
-489 Reduced 7.22%
6,288 $3,000
Q2 2023

Aug 07, 2023

SELL
$1.05 - $1.63 $35,350 - $54,877
-33,667 Reduced 83.24%
6,777 $7,000
Q4 2022

Feb 01, 2023

BUY
$1.71 - $3.61 $15,154 - $31,991
8,862 Added 28.06%
40,444 $75,000
Q3 2022

Nov 09, 2022

SELL
$1.9 - $8.63 $155 - $707
-82 Reduced 0.26%
31,582 $78,000
Q2 2022

Aug 09, 2022

SELL
$2.13 - $9.01 $1,256 - $5,315
-590 Reduced 1.83%
31,664 $77,000
Q1 2022

Apr 21, 2022

SELL
$6.28 - $15.59 $34,954 - $86,773
-5,566 Reduced 14.72%
32,254 $257,000
Q4 2021

Feb 01, 2022

BUY
$14.7 - $28.67 $183,470 - $357,830
12,481 Added 49.26%
37,820 $578,000
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $4,375 - $6,048
-180 Reduced 0.71%
25,339 $720,000
Q2 2021

Jul 30, 2021

BUY
$26.09 - $40.4 $2,530 - $3,918
97 Added 0.38%
25,519 $861,000
Q1 2021

May 03, 2021

BUY
$33.06 - $56.93 $331,823 - $571,406
10,037 Added 65.24%
25,422 $971,000
Q4 2020

Jan 28, 2021

BUY
$39.09 - $57.4 $39,090 - $57,400
1,000 Added 6.95%
15,385 $643,000
Q2 2020

Jul 28, 2020

BUY
$11.71 - $30.29 $76,958 - $199,065
6,572 Added 84.12%
14,385 $436,000
Q1 2020

May 06, 2020

BUY
$7.64 - $27.5 $7,815 - $28,132
1,023 Added 15.07%
7,813 $107,000
Q4 2019

Jan 21, 2020

BUY
$15.02 - $20.57 $34,110 - $46,714
2,271 Added 50.25%
6,790 $110,000
Q2 2019

Jul 30, 2019

BUY
$17.37 - $26.27 $10,526 - $15,919
606 Added 15.49%
4,519 $106,000
Q1 2019

Apr 29, 2019

SELL
$10.65 - $25.75 $9,233 - $22,325
-867 Reduced 18.14%
3,913 $92,000
Q4 2018

Jan 25, 2019

BUY
$9.26 - $16.38 $13,760 - $24,340
1,486 Added 45.11%
4,780 $53,000
Q3 2018

Nov 09, 2018

BUY
$7.54 - $18.31 $6,627 - $16,094
879 Added 36.4%
3,294 $55,000
Q4 2017

Jan 31, 2018

BUY
$7.86 - $9.99 $18,981 - $24,125
2,415
2,415 $22,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.